Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
Objective: The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term usage has been identified as an independent risk factor for atherosclerosis-driven events. The aim of this study...
Saved in:
Main Authors: | Ben Arpad Kappel (Author), Lorenzo De Angelis (Author), Michael Heiser (Author), Marta Ballanti (Author), Robert Stoehr (Author), Claudia Goettsch (Author), Maria Mavilio (Author), Anna Artati (Author), Omero A. Paoluzi (Author), Jerzy Adamski (Author), Geltrude Mingrone (Author), Bart Staels (Author), Remy Burcelin (Author), Giovanni Monteleone (Author), Rossella Menghini (Author), Nikolaus Marx (Author), Massimo Federici (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decreased circulating IPA levels identify subjects with metabolic comorbidities: A multi-omics study
by: Marta Ballanti, et al.
Published: (2024) -
DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection
by: Ángela del Castillo-Izquierdo, et al.
Published: (2022) -
TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
by: Robert Stöhr, et al.
Published: (2015) -
When gut fermentation controls satiety: A PYY story
by: Rémy Burcelin
Published: (2017) -
Gut microbiota and immune crosstalk in metabolic disease
by: Rémy Burcelin
Published: (2016)